Bone Biologics Corporation Share Price Other OTC
Equities
BBLG
US0980702049
Medical Equipment, Supplies & Distribution
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.35M 112M |
---|---|---|---|---|---|
Net income 2024 * | -8M -667M | Net income 2025 * | -8M -667M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.05
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.85% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Frelick
CEO | Chief Executive Officer | 59 | 17/15/17 |
Deina Walsh
DFI | Director of Finance/CFO | 60 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Stroever
BRD | Director/Board Member | 75 | 01/12/01 |
Don Hankey
CHM | Chairman | 81 | 16/18/16 |
Robert Gagnon
BRD | Director/Board Member | 49 | 08/01 |
1st Jan change | Capi. | |
---|---|---|
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B |